Long, Synthetic Staphylococcus aureus Type 8 Capsular Oligosaccharides Reveal Structural Epitopes for Effective...

Area of Science:

• Carbohydrate Chemistry
• Vaccine Development
• Microbiology

Background:

• Staphylococcus aureus causes severe nosocomial infections, with rising multidrug-resistant strains necessitating new treatments.
• Capsular polysaccharides (CPs) of S. aureus are promising vaccine antigens, particularly serotypes 5 and 8.
• CP8 is a complex trisaccharide repeating unit with challenging structural features for synthesis.

Purpose of the Study:

• To synthesize well-defined CP8 fragments of increasing length.
• To investigate the structural and conformational properties of these synthetic CP8 oligosaccharides.
• To evaluate the immunogenicity of CP8 fragments and establish structure-activity relationships for vaccine development.

Main Methods:

• Stereoselective synthesis of CP8 fragments (trimer, hexamer, nonamer, dodecamer).
• Structural analysis to determine oligosaccharide conformation and features.
• Generation of model glycoconjugate vaccines and subsequent antibody generation.
• Immunization studies to assess antibody response and antigenicity.

Main Results:

• Successfully assembled CP8 fragments larger than a single repeating unit for the first time.
• Oligosaccharides adopted a linear conformation with trisaccharide repeats tilted ~90°, stabilized by acetyl groups.
• Identified a length-dependent structure-activity relationship, with a minimum of three repeating units required for adequate immune response.

Conclusions:

• The synthesis of longer CP8 fragments provides valuable tools for understanding S. aureus CP immunogenicity.
• Acetyl groups play a crucial role in stabilizing the oligosaccharide structure and influencing antigenicity.
• A minimum length of three repeating units in CP8 oligosaccharides is essential for eliciting a robust immune response, guiding future vaccine design.